NCT04321096 |
Camostat Mesilate |
Protease inhibition |
I |
NCT04324996 |
Biological: NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2
CAR-NK cells,… |
Secreting super IL15 superagonist and GM-CSF
neutralizing scFv |
II |
NCT04276688 |
Lopinavir/ritonavir; Ribavirin ; Interferon Beta-1B |
Protease and viral mRNA synthesis inhibition |
II |
NCT04280588 |
Fingolimod |
Sphingosine 1-phosphate receptor modulation |
II |
NCT04273529 |
Thalidomide |
Inflammatory cells and cytokines inhibition |
II |
NCT04288102 |
Biological: MScs |
Possessing a comprehensive powerful
immunomodulatory function |
II |
NCT04317092 |
Tocilizumab |
IL-6-mediated signaling inhibition |
II |
NCT04321993 |
Lopinavir/ritonavir; Hydroxychloroquine sulfate;
Baricitinib (janus kinase inhibitor) ; Sarilumab (anti-IL-6 receptor) |
Protease and janus kinase inhibition, anti-IL-6 receptor |
II |
NCT04313023 |
PUL-042 Inhalation Solution |
Reducing the severity of
COVID-19 |
II |
NCT04275245 |
Meplazumab |
Host cell expressed CD147 antibody inhibiting
S protein binding to the cell |
II |
NCT04279197 |
Acetylcysteine |
Mucolytic agent |
II |
NCT04311177 |
Losartan |
Angiotensin II receptor blocker |
II |
NCT04292899 |
Remdesivir |
RNA polymerase inhibition |
III |
NCT04325633 |
Naproxen |
Prostaglandin
G/H synthase inhibition |
III |
NCT04304313 |
Sildenafil citrate |
cGMP specific phosphodiesterase type
5 (PDE5) inhibition |
III |
NCT04320615 |
Tocilizumab (TCZ) |
IL-6-mediated signaling inhibition |
III |
NCT04315896 |
Hydroxychloroquine |
Accumulation and raising the pH of
the vacuole |
III |
NCT04317040 |
CD24Fc |
Regulation of immune responses |
III |
NCT04261270 |
ASC09F+Oseltamivir; Ritonavir+Oseltamivir ; Oseltamivir |
Protease inhibition- neuraminidase inhibition |
III |
NCT04321616 |
Hydroxychloroquine; Remdesivir |
Accumulation and raising
the pH of the vacuole; RNA polymerase inhibition |
III |
NCT04315298 |
Sarilumab |
IL-6-mediated signaling inhibition |
III |
NCT04324021 |
Emapalumab |
Neutralizing the interferon-gamma |
III |
NCT04252274 |
Darunavir and cobicistat |
Protease inhibition- cytochrome
P450 3A (CYP3A) isoforms inhibition |
III |
NCT04308317 |
Tetrandrine |
Not available |
IV |
NCT04286503 |
Carrimycin |
Macrolide antibiotic |
IV |
NCT04254874 |
Arbidol Hydrochloride combined with Interferon atomization |
Dual-acting direct antiviral/host-targeting |
IV |
NCT04263402 |
Methylprednisolone |
Corticosteroid |
IV |
NCT04252885 |
Umifenovir (Arbidol) |
Dual-acting direct antiviral/host-targeting |
IV |
NCT04255017 |
Umifenovir (Arbidol); Oseltamivir; Lopinavir/ritonavir |
Dual-acting
direct antiviral/host-targeting; neuraminidase inhibition; protease
inhibition |
IV |
NCT04291729 |
Drug: Ganovo (Danoprevir )+ritonavir+/-Interferon
nebulization |
Protease inhibition |
IV |